Dendreon Corporation To Webcast Presentation At The Bank of America 2006 Health Care Conference

SEATTLE, May 12 /PRNewswire-FirstCall/ -- Dendreon Corporation today announced that management will present at the Bank of America 2006 Health Care Conference at the Four Seasons Hotel in Las Vegas on Tuesday, May 16 at 4:00 p.m. Pacific Time. The presentation will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com. The replay of the presentation will be available for 90 days.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company uses its experience in antigen identification, antigen engineering and antigen-presenting cell processing to produce active immunotherapy product candidates to potentially stimulate a cell-mediated immune response. PROVENGE (sipuleucel-T) is Dendreon's lead active cellular immunotherapy in Phase 3 development for prostate cancer. The Company also discovered Trp-p8, a cold receptor and transmembrane ion channel in pre-clinical development, which is over-expressed in breast, prostate, lung and colon cancers. For more information about the Company and its programs, visit www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements, particularly those risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov.

Dendreon Corporation

CONTACT: Monique M. Greer, Sr. Director, Corporate Communications ofDendreon Corporation, +1-206-829-1500

Back to news